Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palatability of Patiromer vs Sodium Polystyrene Sulfonate in Healthy Subjects
2019-004696-40Phase 4Completed
- Sponsor
- CSL Vifor
- Start
- Feb 2020
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of patiromer in hyperkalemia (2 arms), sponsored by CSL Vifor. Primary endpoint: Overall acceptability score. Started Feb 2020; status: completed.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on 2019-004696-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004696-40.